A high-throughput assay using dengue-1 virus-like particles for drug discovery

Antiviral Research

Volumn 86, Issue 2, 2010, Pages 163-171

  Qing, Min ^a,b   Liu, Wei ^a   Yuan, Zhiming ^b   Gu, Feng ^a   Shi, Pei Yong ^a  

^a NOVARTIS INSTITUTE FOR TROPICAL DISEASES   (Singapore)

^b WUHAN INSTITUTE OF VIROLOGY   (China)

Author keywords

Dengue; HTS (high throughput screen); Luciferase reporter; VLP (virus like particle)

Indexed keywords

ALPHA GLUCOSIDASE; ANTIVIRUS AGENT; CASTANOSPERMINE; DIMETHYL SULFOXIDE; FURIN; LYCORINE; NEUTRALIZING ANTIBODY; NITD 008; NONSTRUCTURAL PROTEIN 5; PHENOLSULFONPHTHALEIN; RENILLA LUCIFERIN 2 MONOOXYGENASE; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DENGUE VIRUS 1; DRUG SCREENING; ELECTROPORATION; HIGH THROUGHPUT SCREENING; LOW TEMPERATURE; NONHUMAN; PRIORITY JOURNAL; REPLICON; TEMPERATURE DEPENDENCE; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL ASSAY; CELL LINE; CERCOPITHECUS AETHIOPS; CRICETINAE; DENGUE VIRUS; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; ELECTROPORATION; GENES, REPORTER; LUCIFERASES, RENILLA; MACACA MULATTA; VIRAL PROTEINS; VIROSOMES;

DENGUE VIRUS; FLAVIVIRUS; RENILLA LUCIFERASE;

EID: 77951298609     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.02.313     Document Type: Article

References (28)

1. Ansarah-Sobrinho C., Nelson S., Jost C.A., Whitehead S.S., Pierson T.C. Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation. Virology 2008, 38:67-74.
2. Chambers T.J., Hahn C.S., Galler R., Rice C.M. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 1990, 44:649-688.
3. Cherrier M.V., Kaufmann B., Nybakken G.E., Lok S.M., Warren J.T., Chen B.R., Nelson C.A., Kostyuchenko V.A., Holdaway H.A., Chipman P.R., Kuhn R.J., Diamond M.S., Rossmann M.G., Fremont D.H. Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody. EMBO J. 2009, 28:3269-3276.
4. Courageot M.P., Frenkiel M.P., Dos Santos C.D., Deubel V., Desprès P. Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum. J. Virol. 2000, 74:564-572.
5. Crill W.D., Chang G.J. Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J. Virol. 2004, 78:13975-13986.
6. Davis C.W., Nguyen H.Y., Hanna S.L., Sánchez M.D., Doms R.W., Pierson T.C. West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection. J. Virol. 2006, 80:1290-1301.
7. Goto A., Yoshii K., Obara M., Ueki T., Mizutani T., Kariwa H., Takashima I. Role of the N-linked glycans of the prM and E envelope proteins in tick-borne encephalitis virus particle secretion. Vaccine 2005, 23:3043-3052.
8. Gubler D.J., Meltzer M. Impact of dengue/dengue hemorrhagic fever on the developing world. Adv. Virus Res. 1999, 53:35-70.
9. Harvey T.J., Liu W.J., Wang X.J., Linedale R., Jacobs M., Davidson A., Le T.T., Anraku I., Suhrbier A., Shi P.Y., Khromykh A.A. Tetracycline-inducible packaging cell line for production of flavivirus replicon particles. J. Virol. 2004, 78:531-538.
10. Henchal E.A., Gentry M.K., McCown J.M., Brandt W.E. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am. J. Trop. Med. Hyg. 1982, 31:830-836.
11. Jordan I., Briese T., Fischer N., Lau J.Y., Lipkin W.I. Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells. J. Infect. Dis. 2000, 182:1214-1217.
12. Klasse P.J., Sattentau Q.J. Mechanisms of virus neutralization by antibody. Curr. Top. Microbiol. Immunol. 2001, 260:87-108.
13. Kuhn R.J., Zhang W., Rossmann M.G., Pletnev S.V., Corver J., Lenches E., Jones C.T., Mukhopadhyay S., Chipman P.R., Strauss E.G., Baker T.S., Strauss J.H. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 2002, 108:717-725.
14. Lindenbach B.D., Rice C.M. Molecular biology of flaviviruses. Adv. Virus Res. 2003, 59:23-61.
15. Mehlhop E., Ansarah-Sobrinho C., Johnson S., Engle M., Fremont D.H., Pierson T.C., Diamond M.S. Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner. Cell. Host Microbe 2007, 2:417-426.
16. Morrey J.D., Smee D.F., Sidwell R.W., Tseng C. Identification of active antiviral compounds against a New York isolate of West Nile virus. Antiviral Res. 2002, 55:107-116.
17. Puig-Basagoiti F., Deas T.S., Ren P., Tilgner M., Ferguson D.M., Shi P.Y. High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery. Antimicrob. Agents Chemother. 2005, 49:4980-4988.
18. Puig-Basagoiti F., Tilgner M., Forshey B.M., Philpott S.M., Espina N.G., Wentworth D.E., Goebel S.J., Masters P.S., Falgout B., Ren P., Ferguson D.M., Shi P.Y. Triaryl pyrazoline compound inhibits flavivirus RNA replication. Antimicrob. Agents Chemother. 2006, 50:1320-1329.
19. Qing M., Yang F., Zhang B., Zou G., Robida J.M., Yuan Z., Tang H., Shi P.Y. Cyclosporine inhibits flavivirus replication through blocking the interaction between host cyclophilins and viral NS5 protein. Antimicrob. Agents Chemother. 2009, 53:3226-3235.
20. Rajamanonmani R., Nkenfou C., Clancy P., Yau Y.H., Shochat S.G., Sukupolvi-Petty S., Schul W., Diamond M.S., Vasudevan S.G., Lescar J. On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes. J. Gen. Virol. 2009, 90:799-809.
21. Summers P.L., Cohen W.H., Ruiz M.M., Hase T., Eckels K.H. Flaviviruses can mediate fusion from without in Aedes albopictus mosquito cell cultures. Virus Res. 1989, 12:383-392.
22. Whitby K., Pierson T.C., Geiss B., Lane K., Engle M., Zhou Y., Doms R.W., Diamond M.S. Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo. J. Virol. 2005, 79:8698-8706.
23. Wu S.F., Lee C.J., Liao C.L., Dwek R.A., Zitzmann N., Lin Y.L. Antiviral effects of an iminosugar derivative on flavivirus infections. J. Virol. 2002, 76:3596-3604.
24. Yin Z., Chen Y.L., Schul W., Wang Q.Y., Gu F., Duraiswamy J., Kondreddi R.R., Niyomrattanakit P., Lakshminarayana S.B., Goh A., Xu H.Y., Liu W., Liu B., Lim J.Y., Ng C.Y., Qing M., Lim C.C., Yip A., Wang G., Chan W.L., Tan H.P., Lin K., Zhang B., Zou G., Bernard K.A., Garrett C., Beltz K., Dong M., Weaver M., He H., Pichota A., Dartois V., Keller T.H., Shi P.Y. An adenosine nucleoside inhibitor of dengue virus. Proc. Natl. Acad. Sci. 2009, 106:20435-20439.
25. Yu I.M., Holdaway H.A., Chipman P.R., Kuhn R.J., Rossmann M.G., Chen J. Association of the pr peptides with dengue virus at acidic pH blocks membrane fusion. J. Virol. 2009, 83:12101-12107.
26. Zhang J.H., Chung T.D., Oldenburg K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 1999, 4:67-73.
27. Zou G., Puig-Basagoiti F., Zhang B., Qing M., Chen L., Pankiewicz K.W., Felczak K., Yuan Z., Shi P.Y. A single-amino acid substitution in West Nile virus 2K peptide between NS4A and NS4B confers resistance to lycorine, a flavivirus inhibitor. Virology 2009, 384:242-252.
28. Zybert I.A., van der Ende-Metselaar H., Wilschut J., Smit J.M. Functional importance of dengue virus maturation: infectious properties of immature virions. J. Gen. Virol. 2008, 89:3047-3051.